Kohn; Donald B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kohn; Donald B..The latest application filed is for "augmentations to lentiviral vectors (cclc-mgata/ank-core lcr-beta-as3-fb) to increase expression".

Company Profile

4.2.11

Kohn; Donald B. - Tarzana CA
Kohn; Donald B. - Los Angeles CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Augmentations To Lentiviral Vectors (cclc-mgata/ank-core Lcr-beta-as3-fb) To Increase Expression App 20220170045 - Kohn; Donald B. ; et al.	2022-06-02
Optimized Lentiviral Vector Compromising Minimal Enhancer Elements For Stem Cell Gene Therapy Of Hemoglobinopathies App 20220136007 - Kohn; Donald B. ; et al.	2022-05-05
Gene Editing Of Monogenic Disorders In Human Hematopoietic Stem Cells -- Correction Of X-linked Agammaglobulinemia (xla) App 20210379105 - Kohn; Donald B. ; et al.	2021-12-09
Methods For Treating Sickle Cell Disease App 20210155927 - DeWitt; Mark A. ; et al.	2021-05-27
Lentiviral Vectors Expressing Foxp3 In Hematopoietic Stem Cells To Treat Immune Deficiencies And Autoimmune Diseases App 20200347404 - Kohn; Donald B. ; et al.	2020-11-05
Optimized Lentiviral Vector For Stem Cell Gene Therapy Of Hemoglobinopathies App 20200109416 - Kohn; Donald B. ; et al.	2020-04-09
Methods And Compositions For Gene Editing In Stem Cells App 20190249172 - Kohn; Donald B. ; et al.	2019-08-15
Retroviral Vectors Containing A Reverse Orientation Human Ubiquitin C Promoter App 20180185415 - Kohn; Donald B. ; et al.	2018-07-05
Lentiviral Vector For Stem Cell Gene Therapy Of Sickle Cell Disease App 20170157270 - Kohn; Donald B. ; et al.	2017-06-08
Lentiviral Vector For Stem Cell Gene Therapy Of Sickle Cell Disease App 20150224209 - Kohn; Donald B. ; et al.	2015-08-13
Gene therapy by administration of genetically engineered CD34.sup.+ cells obtained from cord blood Grant 6,984,379 - Kohn , et al. January 10, 2	2006-01-10
Retroviral vectors for expression in embryonic cells Grant 5,707,865 - Kohn , et al. January 13, 1	1998-01-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.